Comments

Comments on CMS’s update of the National Coverage Determination (NCD) for hepatitis C screening

CDC has reported that hepatitis C kills more Americans than sixty other notifiable infectious diseases combined, and it still contributes to over 11,000 deaths a year, even though it can be cured.  Even now, over a decade after curative treatments have been available, CDC found that only one in three people with evidence of infection had been cured, and the number of US adults estimated to be living with HCV was 2.5 to 4 million in 2017-2020, a prevalence unchanged from 2013-2016. Many of the easiest people to reach, those in primary care and traditional health care settings, have already accessed curative treatment.  We urge CMS to issue this NCD without setting restrictions so that as many Medicare beneficiaries as possible can access these curative treatments. 

read more

Comments to the Oregon PDAB on PBM Practices and Continuity of Care

We strongly support the Board’s recommendation to strengthen PBM oversight through standardized financial reporting, disclosure of affiliated businesses, independent audit authority, and greater public transparency. PBMs play a significant role in determining which medications patients can access and how much they pay at the pharmacy counter. Yet complex financial arrangements make it difficult to determine whether negotiated rebates and discounts ultimately benefit patients.

read more

Pin It on Pinterest